Zobrazeno 1 - 10
of 42
pro vyhledávání: '"R. Altena"'
Publikováno v:
Cardio-Oncology, Vol 6, Iss 1, Pp 1-12 (2020)
Abstract Background In cardio-oncology, a range of clinical dilemmas can be identified where high-quality evidence for management is still lacking. The aim of this project was to study clinical practices and expert approaches to several clinical card
Externí odkaz:
https://doaj.org/article/c01bdb6b58574dccb235dc583f27f111
Publikováno v:
Annals of Oncology. 31:S54
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f40ef209ca80b6c8a8362d0cb9eb14ad
https://doi.org/10.1016/j.annonc.2020.03.218
https://doi.org/10.1016/j.annonc.2020.03.218
Autor:
Susan J. J. Logtenberg, Klaas H. Groenier, Nanne Kleefstra, Henk J. G. Bilo, Mariette R. Altena, Sebastiaan T. Houweling
Publikováno v:
Blood Pressure, 18(5), 273-279. Taylor & Francis Group
Hypertension is a chronic disorder with a high prevalence worldwide. Despite considerable efforts, it is sometimes hard to reach treatment goals for blood pressure (BP) with classical treatment options. Reducing breathing frequency has been advocated
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::151961313668e0182ed05bf8e3074dcb
https://research.rug.nl/en/publications/53b42a22-0d3d-4a3c-8642-6343fd6f9c89
https://research.rug.nl/en/publications/53b42a22-0d3d-4a3c-8642-6343fd6f9c89
Autor:
A. H. Boekhout, R. Altena
Publikováno v:
Journal of Clinical Oncology. 28:TPS108-TPS108
TPS108 Background: Trastuzumab-associated cardiotoxicity leads to morbidity and a potentially less optimal treatment in a part of patients (pts) adjuvantly treated for HER2+ breast cancer (BC). Interventions that reduce the chance to develop this tox
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::610902f306b4c93dc9b97f961b949f22
https://doi.org/10.1200/jco.2010.28.15_suppl.tps108
https://doi.org/10.1200/jco.2010.28.15_suppl.tps108
Publikováno v:
European Journal of Oncology Nursing. 14:S2
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7338c5dc6fb1695656819a4d78bfeacf
https://doi.org/10.1016/s1462-3889(10)70014-4
https://doi.org/10.1016/s1462-3889(10)70014-4
Autor:
Schouten AEM; Department of Epidemiology and Health Economics, Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht University, Utrecht, the Netherlands., Hiensch AE; Department of Epidemiology and Health Economics, Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht University, Utrecht, the Netherlands., Frederix GWJ; Department of Epidemiology and Health Economics, Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht University, Utrecht, the Netherlands., Monninkhof EM; Department of Epidemiology and Health Economics, Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht University, Utrecht, the Netherlands., Schmidt ME; Division of Physical Activity, Prevention and Cancer, German Cancer Research Center (DKFZ) and National Center for Tumor Diseases (NCT) Heidelberg, A Partnership Between DKFZ and University Medical Center Heidelberg, Heidelberg, Germany., Clauss D; Department of Molecular and Cellular Sports Medicine, Institute of Cardiovascular Research and Sports Medicine, German Sport University Cologne, Cologne, Germany., Gunasekara N; Department for Molecular and Cellular Sports Medicine, German Sport University Cologne, Cologne, Germany., Belloso J; Gipuzkoa Cancer Unit, OSID-Onkologikoa, BioGipuzkoa, Osakidetza, San Sebastian, Spain., Trevaskis M; Mary MacKillop Institute for Health Research, Australian Catholic University, Melbourne, Victoria, Australia., Rundqvist H; Department of Laboratory Medicine, Karolinska Institutet and Unit of Clinical Physiology, Karolinska University Hospital, Stockholm, Sweden., Wiskemann J; Working Group Exercise Oncology, Division of Medical Oncology, Heidelberg University Hospital and NCT Heidelberg, A Partnership Between DKFZ and University Medical Center Heidelberg, Heidelberg, Germany., Müller J; Heidelberg University Hospital and NCT Heidelberg, A Partnership Between DKFZ and University Medical Center Heidelberg, Heidelberg, Germany., Sweegers MG; Division of Psychosocial Research and Epidemiology & Center for Quality of Life, Netherlands Cancer Institute, Amsterdam, the Netherlands., Fremd C; National Center for Tumor Diseases (NCT), University Hospital Heidelberg, Germany, German Cancer Research Center Heidelberg (DKFZ), Heidelberg, Germany., Altena R; Department of Oncology-Pathology, Karolinska Institutet and Karolinska Comprehensive Cancer Center, Karolinska University Hospital, Stockholm, Sweden., Bijlsma RM; Department of Medical Oncology, University Medical Center Utrecht, Utrecht University, Utrecht, the Netherlands., Sonke G; Breast Cancer Center, Netherlands Cancer Institute, Amsterdam, the Netherlands., Lahuerta A; Gipuzkoa Cancer Unit, OSID-Onkologikoa, BioGipuzkoa, Osakidetza, San Sebastian, Spain., Mann GB; Royal Melbourne Hospital, Melbourne, Victoria, Australia., Francis PA; Peter MacCallum Cancer Center, Sir Peter MacCallum Department of Oncology, The University of Melbourne, Melbourne, VIC, Australia., Richardson G; Cabrini Cancer Institute, Cabrini Health, Melbourne, Victoria, Australia., Malter W; University of Cologne, Faculty of Medicine and University Hospital Cologne, Department of Gynecology and Obstetrics, Breast Center, CIO., Kufel-Grabowska J; Greater Poland Cancer Centre, Poznan, Poland., van der Wall E; Department of Medical Oncology, University Medical Center Utrecht, Utrecht University, Utrecht, the Netherlands., Aaronson NK; Department of Psychosocial Research and Epidemiology, Netherlands Cancer Institute, Amsterdam, the Netherlands., Senkus E; Department of Oncology and Radiotherapy, Medical University of Gdańsk, Gdańsk, Poland., Urruticoechea A; Gipuzkoa Cancer Unit, OSID-Onkologikoa, BioGipuzkoa, Osakidetza, San Sebastian, Spain., Zopf EM; Cabrini Cancer Institute, Cabrini Health, Melbourne, Victoria, Australia.; Mary MacKillop Institute for Health Research, Australian Catholic University, Melbourne, Victoria, Australia., Bloch W; Department of Molecular and Cellular Sports Medicine, Institute of Cardiovascular Research and Sports Medicine, German Sport University Cologne, Cologne, Germany., Stuiver MM; Division of Psychosocial Research and Epidemiology & Center for Quality of Life, Netherlands Cancer Institute, Amsterdam, the Netherlands., Wengstrom Y; Karolinska Institutet and Karolinska Comprehensive Cancer Center, Karolinska University Hospital, Stockholm, Sweden., Steindorf K; Division of Physical Activity, Prevention and Cancer, German Cancer Research Center (DKFZ) and National Center for Tumor Diseases (NCT) Heidelberg, A Partnership Between DKFZ and University Medical Center Heidelberg, Heidelberg, Germany., van der Meulen MP; Department of Epidemiology and Health Economics, Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht University, Utrecht, the Netherlands., May AM; Department of Epidemiology and Health Economics, Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht University, Utrecht, the Netherlands.
Publikováno v:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology [J Clin Oncol] 2025 Jan 13, pp. JCO2401441. Date of Electronic Publication: 2025 Jan 13.
Autor:
Ten Hoor MBC; Department of Surgical Oncology, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands., Lin JF; Department of Surgical Oncology, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands., Metman MJH; Department of Surgical Oncology, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands., Rodriguez Schaap PM; Department of Surgery, Amsterdam University Medical Centre, Location VUmc Cancer Centre Amsterdam, Amsterdam, the Netherlands., Links TP; Department of Internal Medicine, Division of Endocrinology, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands., Altena R; Karolinska Comprehensive Cancer Center, Karolinska University Hospital, Stockholm, Sweden.; Institution for Oncology-Pathology, Karolinska Institutet, Stockholm, Sweden.; Department of Nuclear Medicine, Function Medical Diagnostics, Karolinska University Hospital, Stockholm, Sweden., van Ginhoven TM; Department of Surgery, Erasmus Medical Center, Erasmus University, Rotterdam, The Netherlands., Zandee WT; Department of Internal Medicine, Division of Endocrinology, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands., Engelsman AF; Department of Surgery, Amsterdam University Medical Centre, Location VUmc Cancer Centre Amsterdam, Amsterdam, the Netherlands., Kruijff S; Department of Surgical Oncology, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands.; Department of Nuclear Medicine and Molecular Imaging, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands.; Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden.
Publikováno v:
World journal of surgery [World J Surg] 2024 Dec 25. Date of Electronic Publication: 2024 Dec 25.
Autor:
Hiensch AE; Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands., Depenbusch J; German Cancer Research Center (DKFZ) and National Center for Tumor Diseases (NCT, a partnership between DKFZ and University Medical Center Heidelberg) Heidelberg, Heidelberg, Germany., Schmidt ME; German Cancer Research Center (DKFZ) and National Center for Tumor Diseases (NCT, a partnership between DKFZ and University Medical Center Heidelberg) Heidelberg, Heidelberg, Germany., Monninkhof EM; Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands., Pelaez M; Gipuzkoa Cancer Unit, OSID-Onkologikoa, BioGipuzkoa, Osakidetza, San Sebastian, Spain.; Universidad Europea del Atlantico, Santander, Spain., Clauss D; German Sport University Cologne, Cologne, Germany., Gunasekara N; German Sport University Cologne, Cologne, Germany., Zimmer P; TU Dortmund University, Dortmund, Germany., Belloso J; Gipuzkoa Cancer Unit, OSID-Onkologikoa, BioGipuzkoa, Osakidetza, San Sebastian, Spain., Trevaskis M; Mary MacKillop Institute for Health Research, Australian Catholic University, Melbourne, Victoria, Australia., Rundqvist H; Department of Laboratory Medicine, Karolinska Institutet and Unit of Clinical Physiology, Karolinska University Hospital, Stockholm, Sweden., Wiskemann J; Heidelberg University Hospital and NCT Heidelberg (a partnership between DKFZ and University Medical Center Heidelberg), Heidelberg, Germany., Müller J; Heidelberg University Hospital and NCT Heidelberg (a partnership between DKFZ and University Medical Center Heidelberg), Heidelberg, Germany., Sweegers MG; Netherlands Cancer Institute, Amsterdam, The Netherlands., Fremd C; Department of Medical Oncology, National Center for Tumor Diseases (NCT), University Hospital Heidelberg, Heidelberg, Germany.; Divison of Gynecologic Oncology, National Center for Tumor Diseases (NCT), University Hospital Heidelberg, Heidelberg, Germany.; German Cancer Research Center Heidelberg (DKFZ), Heidelberg, Germany., Altena R; Karolinska Institutet, Unit for Nursing, Karolinska Comprehensive Cancer Center, Breast and Sarcoma Unit, Karolinska University Hospital, Solna, Sweden., Gorecki M; Greater Poland Cancer Centre, Poznan, Poland., Bijlsma R; Division of Imaging and Oncology, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands., van Leeuwen-Snoeks L; Diakonessenhuis Utrecht-Zeist-Doorn, Utrecht, The Netherlands., Ten Bokkel Huinink D; Alexander Monro Ziekenhuis, Bilthoven, The Netherlands., Sonke G; Netherlands Cancer Institute, Amsterdam, The Netherlands., Lahuerta A; Gipuzkoa Cancer Unit, OSID-Onkologikoa, BioGipuzkoa, Osakidetza, San Sebastian, Spain., Mann GB; Royal Melbourne Hospital, Melbourne, Victoria, Australia.; Peter MacCallum Cancer Centre, The University of Melbourne, Victoria, Australia., Francis PA; Peter MacCallum Cancer Centre, The University of Melbourne, Victoria, Australia., Richardson G; Cabrini Research, Cabrini Health, Malvern, Victoria, Australia., Malter W; Center for Familial Breast and Ovarian Cancer, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany., van der Wall E; Division of Imaging and Oncology, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands., Aaronson NK; Netherlands Cancer Institute, Amsterdam, The Netherlands., Senkus E; Medical University of Gdańsk, Gdańsk, Poland., Urruticoechea A; Gipuzkoa Cancer Unit, OSID-Onkologikoa, BioGipuzkoa, Osakidetza, San Sebastian, Spain., Zopf EM; Mary MacKillop Institute for Health Research, Australian Catholic University, Melbourne, Victoria, Australia.; Cabrini Research, Cabrini Health, Malvern, Victoria, Australia., Bloch W; German Sport University Cologne, Cologne, Germany., Stuiver MM; Netherlands Cancer Institute, Amsterdam, The Netherlands., Wengstrom Y; Karolinska Institutet, Unit for Nursing, Karolinska Comprehensive Cancer Center, Breast and Sarcoma Unit, Karolinska University Hospital, Solna, Sweden., Steindorf K; German Cancer Research Center (DKFZ) and National Center for Tumor Diseases (NCT, a partnership between DKFZ and University Medical Center Heidelberg) Heidelberg, Heidelberg, Germany., May AM; Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands. a.m.may@umcutrecht.nl.
Publikováno v:
Nature medicine [Nat Med] 2024 Oct; Vol. 30 (10), pp. 2957-2966. Date of Electronic Publication: 2024 Jul 25.
Autor:
Vasileva-Slaveva M; Bulgarian Breast and Other Gynecological Cancers Association, Sofia, Mladost 1, 1750, Block 122, Bulgaria; Shterev Hospital, Sofia, 1330, Hristo Blagoev 25, Bulgaria; Medical University Pleven, Pleven, 5800, Blvd Kliment Ohridski 1, Bulgaria. Electronic address: info@bbca.bg., Morales-Espinosa D; Affimed GmbH Gottlieb-Daimler-Straße 2, 68165 Mannheim, Germany., Puccini A; IRCCS, Humanitas Research Hospital, Humanitas Cancer Center, Medical Oncology and Hematology Unit Rozzano, Via Alessandro Manzoni, 56, 20089, Rozzano, Milan, Italy., Meissner M; Cardiff University - Division of Cancer and Genetics, School of Medicine, Cardiff University, Sir Geraint Evans Building, Heath Park, CF14 4XN, Cardiff, United Kingdom; Velindre NHS Trust, Velindre Cancer Centre, Velindre Road, Cardiff, CF14 2TL, United Kingdom., Milic M; University College London Hospitals NHS Foundation Trust, 250 Euston Road, NW1 2PG, London, United Kingdom., Lamberti G; Department of Medical and Surgical Sciences, University of Bologna, Via Zamboni, 33, 40126, Bologna, Italy., Altena R; Medical Unit Breast, Endocrine Tumors and Sarcoma, Karolinska Comprehensive Cancer Center, Karolinska University Hospital, Eugeniavägen 3, 171 76, Solna, Sweden; Inst. Onk-Pat, Karolinska Institutet, Stockholm, Sweden.
Publikováno v:
European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology [Eur J Surg Oncol] 2024 Jun; Vol. 50 (6), pp. 108031. Date of Electronic Publication: 2024 Mar 06.
Autor:
Eissler N; Affibody AB, 17165 Solna, Sweden., Altena R; Department of Oncology-Pathology, Karolinska Institutet, 17164 Solna, Sweden.; Medical Unit Breast, Endocrine Tumors and Sarcoma, Theme Cancer, Karolinska Comprehensive Cancer Center, Karolinska University Hospital, 17164 Solna, Sweden.; Medical Radiation Physics and Nuclear Medicine, Functional Unit of Nuclear Medicine, Karolinska University Hospital, 14157 Huddinge, Sweden., Alhuseinalkhudhur A; Nuclear Medicine and PET, Department of Surgical Sciences, Uppsala University, 75310 Uppsala, Sweden.; Department of Immunology, Genetics and Pathology, Uppsala University, 75310 Uppsala, Sweden., Bragina O; Department of Nuclear Therapy and Diagnostic, Cancer Research Institute, Tomsk National Research Medical Center, Russian Academy of Sciences, 634055 Tomsk, Russia.; Research Centrum for Oncotheranostics, Research School of Chemistry and Applied Biomedical Sciences, Tomsk Polytechnic University, 634050 Tomsk, Russia., Feldwisch J; Affibody AB, 17165 Solna, Sweden., Wuerth G; Affibody AB, 17165 Solna, Sweden., Loftenius A; Affibody AB, 17165 Solna, Sweden., Brun N; Affibody AB, 17165 Solna, Sweden., Axelsson R; Medical Radiation Physics and Nuclear Medicine, Functional Unit of Nuclear Medicine, Karolinska University Hospital, 14157 Huddinge, Sweden.; Department of Molecular Medicine and Surgery, Karolinska Institutet, 14152 Stockholm, Sweden., Tolmachev V; Department of Immunology, Genetics and Pathology, Uppsala University, 75310 Uppsala, Sweden., Sörensen J; Nuclear Medicine and PET, Department of Surgical Sciences, Uppsala University, 75310 Uppsala, Sweden., Frejd FY; Affibody AB, 17165 Solna, Sweden.; Department of Immunology, Genetics and Pathology, Uppsala University, 75310 Uppsala, Sweden.
Publikováno v:
Biomedicines [Biomedicines] 2024 May 14; Vol. 12 (5). Date of Electronic Publication: 2024 May 14.